In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a medobiotin Drug Master File in Korea (medobiotin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of medobiotin. The MFDS reviews the medobiotin KDMF as part of the drug registration process and uses the information provided in the medobiotin KDMF to evaluate the safety and efficacy of the drug.
After submitting a medobiotin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their medobiotin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of medobiotin suppliers with KDMF on PharmaCompass.